Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Corcept Therapeutics

    NASDAQ: CORT · Real-Time Price · USD
    71.95
    -0.05 (-0.07%)
    At close: Aug 15, 2025, 3:04 PM

    Corcept Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 675.04M 482.38M 401.86M 365.98M
    Cost of Revenue
    		 10.88M 6.48M 5.38M 5.28M
    Gross Profit
    		 664.16M 475.89M 396.47M 360.7M
    Operating Income
    		 136.95M 107.28M 112.63M 124.48M
    Interest Income
    		 24.54M 17.27M 3.56M 529K
    Pretax Income
    		 161.49M 124.56M 116.19M 125.01M
    Net Income
    		 139.73M 106.14M 101.42M 112.51M
    Selling & General & Admin
    		 280.32M 184.26M 152.85M 122.36M
    Research & Development
    		 246.89M 184.35M 130.99M 113.86M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 527.21M 368.61M 283.84M 236.22M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 538.09M 375.09M 289.22M 241.5M
    Income Tax Expense
    		 20.28M 18.42M 14.77M 12.49M
    Shares Outstanding (Basic)
    		 103.23M 103.56M 106.79M 115.65M
    Shares Outstanding (Diluted)
    		 113.48M 111.74M 115.97M 125.96M
    EPS (Basic)
    		 1.35 1.02 0.95 0.97
    EPS (Diluted)
    		 1.23 0.94 0.87 0.89
    EBITDA
    		 136.95M 108.32M 113.89M 127.95M
    EBIT
    		 136.95M 107.28M 112.63M 125.01M
    Depreciation & Amortization
    		 n/a 1.04M 1.26M 3.07M

    Add to Watchlist